We are live on ! Find out more
BG

Bellevue Group Portfolio holdings

AUM $4.2B
1-Year Est. Return 54.85%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+54.85%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.2B
AUM Growth
-$1.07B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
195
New
Increased
Reduced
Closed

Top Buys

1
+$203M
2
+$156M
3
+$146M
4
AMGN icon
Amgen
AMGN
+$98.7M
5
VRDN icon
Viridian Therapeutics
VRDN
+$70.3M

Top Sells

1
+$350M
2
+$235M
3
+$225M
4
RNAM
Avidity Biosciences
RNAM
+$190M
5
FOLD
Amicus Therapeutics
FOLD
+$153M

Sector Composition

1 Healthcare 99.74%
2 Energy 0.07%
3 Technology 0.06%
4 Financials 0.03%
5 Consumer Discretionary 0.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORCL icon
151
Oracle
ORCL
$428B
$28.1K ﹤0.01%
191
-12
DGX icon
152
Quest Diagnostics
DGX
$23.2B
$25.7K ﹤0.01%
131
-7,149
QCOM icon
153
Qualcomm
QCOM
$200B
$25.4K ﹤0.01%
197
-12
RXRX icon
154
Recursion Pharmaceuticals
RXRX
$1.87B
$14.2K ﹤0.01%
4,627
-294
QGEN icon
155
Qiagen
QGEN
$8.13B
$9.73K ﹤0.01%
+243
AMRX icon
156
Amneal Pharmaceuticals
AMRX
$5.5B
– –
-7,913
ANET icon
157
Arista Networks
ANET
$198B
– –
-4,800
APLS
158
DELISTED
Apellis Pharmaceuticals
APLS
– –
-4,210
AVTR icon
159
Avantor
AVTR
$7.02B
– –
-276,266
AZN icon
160
AstraZeneca
AZN
$292B
– –
-30,431
BEAM icon
161
Beam Therapeutics
BEAM
$3.58B
– –
-111,510
BKD icon
162
Brookdale Senior Living
BKD
$3.75B
– –
-167,444
BMRN icon
163
BioMarin Pharmaceuticals
BMRN
$11.4B
– –
-65,008
CDNA icon
164
CareDx
CDNA
$1.49B
– –
-431,070
CGON icon
165
CG Oncology
CGON
$6.35B
– –
-3,095
CMPS
166
Compass Pathways
CMPS
$2B
– –
-142,243
CORT icon
167
Corcept Therapeutics
CORT
$9.37B
– –
-10,495
DOCS icon
168
Doximity
DOCS
$3.82B
– –
-11,817
EXAS
169
DELISTED
Exact Sciences
EXAS
– –
-16,062
EXEL icon
170
Exelixis
EXEL
$13.8B
– –
-7,361
FOLD
171
DELISTED
Amicus Therapeutics
FOLD
– –
-10,735,195
GH icon
172
Guardant Health
GH
$19.8B
– –
-3,004
GMAB icon
173
Genmab
GMAB
$16B
– –
-3,009
ICLR icon
174
Icon
ICLR
$13B
– –
-24,560
IDYA icon
175
IDEAYA Biosciences
IDYA
$3.54B
– –
-4,942
4 5 6
7
8